Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
ALT
Altimmune Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for ALT
Full ALT profile on Quantisnow Follow ALT and get a push notification the moment its next story breaks.